Membranoproliferative glomerulonephritis associated with small cell lung carcinoma

Area of Science:

• Nephrology
• Oncology
• Pathology

Background:

• Nephropathy, particularly nephrotic syndrome, is a known complication associated with malignant solid tumors and lymphoproliferative disorders.
• Membranous glomerulonephritis (MGN) is the most frequently observed glomerular disease in patients with solid tumors.
• The association between membranoproliferative glomerulonephritis (MPGN) and solid tumors, especially lung carcinoma, is considered uncommon.

Observation:

• A 45-year-old male patient presented with nephrotic syndrome.
• Renal biopsy revealed membranoproliferative glomerulonephritis (MPGN) as the underlying cause of nephrotic syndrome.
• The clinical presentation suggested a paraneoplastic syndrome.

Findings:

• This case represents the first reported instance of membranoproliferative glomerulonephritis (MPGN) associated with lung cancer.
• The patient's nephrotic syndrome was attributed to MPGN, likely as a manifestation of a paraneoplastic process.
• This finding expands the spectrum of glomerular diseases linked to paraneoplastic syndromes.

Implications:

• Highlights the importance of considering underlying malignancies in patients presenting with unexplained nephrotic syndrome, even with rarer glomerular lesions like MPGN.
• Suggests that lung cancer should be investigated in patients with MPGN and nephrotic syndrome, particularly in middle-aged adults.
• Underscores the need for further research into the mechanisms linking MPGN to paraneoplastic syndromes and solid tumors.